From January 1 to September 30, 2024, a total of 20 items were approved to acquiesce in clinical trials (implied approval for clinical trials), of which 17 items were derived from mesenchymal stem cells.

As a new frontier of medicine, cell and gene therapy is showing great potential and development momentum. Especially in the treatment of refractory diseases, more and more clinical trials of cell and gene therapy are being opened.

China has made major breakthroughs in gene therapy technology and is expected to provide accessibility and curative drugs for patients with serious diseases.

With the development of regenerative medicine, cell therapies represented by stem cells have broad application prospects in the field of anti-aging, helping to delay aging, fight aging-related diseases, and enhance the body's immunity.

Recently, good news has come again in the field of diabetes, and China and foreign countries have made breakthroughs!

The emergence of regenerative therapies such as stem cells has brought new light to patients with rheumatoid arthritis and osteoarthritis!

iPSC regenerative medicine will open a new era of treatment.

Recently, good news has come again in the field of diabetes, and China and foreign countries have made breakthroughs!